
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo Corp demonstrated a strong financial performance with driver shipments reaching 65,000, surpassing expectations, and reflecting an 8% quarter-over-quarter and 11% year-over-year growth. The company's gross margin increased by 240 basis points year-over-year, while operating margin improved by 570 basis points, indicating enhanced operational efficiencies and profitability. Additionally, management reaffirmed revenue guidance for 2025, projecting an 8-11% growth, and raised EPS guidance, suggesting strong future earnings potential driven by innovations in healthcare and consumer segments.
Bears say
Masimo Corp's financial outlook is increasingly concerning, as the company's revenue growth has decelerated, declining on an organic basis in 2023, with both healthcare and non-healthcare segments experiencing downturns. The revised revenue estimates for 2025 and 2026 have been significantly cut, reflecting a greater than anticipated slowdown in revenue growth and ongoing challenges with margin improvement and new product sales. Additionally, risks such as potential tariff impacts on costs, ongoing supply chain disruptions, and continued market share losses further exacerbate the negative sentiment surrounding the company's financial health.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares